ligands acting on targets

A radiopharmaceutical precursor.

19-Hydroxycortisol.

19-Noretiocholanolone-d5.

19-Norprogesterone is a close analogue of the steroid progesterone, lacking only the C-19 methyl group of that molecule. In 1953, it was discovered that a preparation of 19-Norprogesterone yielded results equivalent to progesterone in assays

19-Oxocinobufagin is a bufadienolide in toad venom.

19-Oxocinobufagin is a bufadienolide in toad venom.

19-Oxocinobufagin is a bufadienolide in toad venom.

19-Phenylnonadecanoic acid.

19-Phenylnonadecanoic acid.

Prostaglandin E1 (PGE1) is not a major naturally occurring PG, but it is widely administered clinically for several indications including peripheral occlusive vascular disease, neonatal cardiology and erectile dysfunction. COX metabolism of the

Prostaglandin E1 (PGE1) is not a major naturally occurring PG, but it is widely administered clinically for several indications including peripheral occlusive vascular disease, neonatal cardiology and erectile dysfunction. COX metabolism of the

1a,1b-dihomo Prostaglandin F2α is believed to be the metabolic product of adrenic acid via degradation by COX. 1a,1b-dihomo Prostaglandin F2α is primarily produced in renal medulla tissue where adrenic acid is selectively distributed.